The occurrence of resistance to antiseptics and disinfectants in clinical isolates of coagulase-negative staphylococci (CNS) was examined. Of 164 clinical strains of CNS isolated in the early 1980s, 65 were resistant to cationic antimicrobial compounds such as cetyltrimethylammonium bromide. Further characterisation of 40 resistant isolates by DNA-DNA hybridisation analysis and phenotypic resistance studies revealed that this resistance was mediated by the multidrug export genes qacA and qacC, characterised previously in Staphylococcus aureus. Of the resistant CNS isolates, 50 YO contained only qacA, 10% contained only qacC, and the remaining 40% contained both qacA and qacC. Both qacA and qacC genes resided on plasmids in all cases, with qacA located on plasmids of > 10 kb, whereas qacC was located primarily on plasmids of 2-3 kb. Representative qacA and qacC plasmids were characterised by restriction endonuclease mapping, and were found to be similar in some cases, but different in others, to those plasmids on which these genes are found in S. aureus.
Introduction
Multidrug resistance to organic cationic antiseptic and disinfectant compounds, such as cetyltrimethylammonium bromide (Ct) and benzalkonium chloride (Bc), has been reported in clinical isolates of Staphylococcus aureus from Australia, Europe, Asia and North America.'. Resistance to these compounds has also been characterised in various other organisms, including Bacillus ~u b t i l i s ,~ Escherichia c01i43 and Klebsiella aerogenes.' This multidrug resistance is mediated by active export of the toxic compounds from the cell by means of the proton motive f~r c e .~,~,~, The wide distribution and broad substrate specificity of these resistance determinants suggests that they may be important elements of an organism's potential to survive in a hospital environment. ' Antiseptic and disinfectant resistance in S . aureus is encoded by one of at least three separate multidrug resistance determinants, designated qacA, qacB and qa~C.~-' The qacA gene confers the broadest resistance phenotype, including resistance to four classes of compounds : the intercalating dyes such as ethidium bromide (Eb) and proflavine (Po; the quaternary ammonium compounds such as Ct and Bc; the diamidines such as propamidine isethionate (Pi) and diamidinodiphenylamine dihydrochloride (Dd) ; and the biguanidines such as chlorhexidine (Ch). 7 The qacA gene is located predominantly on members of the pSKl family of multiresistance plasrnids,l0. l1 but has been found also on b-lactamase and heavy-metal resistance plasmids, such as pSK57,12 and may be located chromosomally in some S. aureus clinical is01ates.l~ The qacB gene is almost identical at a nucleotide sequence level to qacA (personal unpublished results), but specifies resistance only to the intercalating dyes and quaternary ammonium comp o u n d~.~ The qacB gene has been found on blactamase and heavy-metal resistance plasmids such as pSK23.l The qacC gene, which is identical to ebr14 and srnr,15 encodes resistance to Eb and some quaternary ammonium c~m p o u n d s ,~ and is located typically either on small (< 3-kb) plasmids, such as pSK89, or on large (c. 50-kb) conjugative plasmids, such as pSK41.'~~'
In recent years, coagulase-negative staphylococci (CNS) have been recognised increasingly as important causative organisms of infections associated with implanted foreign bodies-such as prosthetic heart valves, prosthetic joints, intravenous catheters, cerebrospinal fluid shunts and peritoneal dialysis catheters-and in patients with compromised host defences. [17] [18] [19] The mortality rate of CNS infection in some cases, e.g., bacteraemia, is similar to the mortality rate reported with S. aureus. 20 
Materials and methods

Bacterial strains and plasmids
In total, 164 CNS strains were selected from a collection of multiresistant clinical isolates obtained from Australian hospitals during 1 979-1984. 21 The plasmid-free S. aureus strain SK98222 was used as a recipient in the plasmid transfer experiments and as a control in the MIC determinations and DNA hybridisation experiments. S. aureus strains SK2355,23 carrying pSK 1 (qacA), SK2725,7 carrying pSK23 (qacB), and SK272 1 ,7 carrying pSK89 (qacC), were also used as controls in the MIC determinations and in the DNA hybridisation experiments.
General procedures
The media and method used for the determination of susceptibility to antimicrobial compounds have been described p r e v i o~s l y .~~ MICs of Bc, Ch, Ct, Dd, Eb, Pf, Pi, and a 1 : 10 mixture of Ch and Ct were determined by the agar dilution method as described p r e v i~u s l y .~,~~ MIC tests were performed in at least triplicate. Resistant isolates were defined as those able to grow at or above the following concentrations (mg/L) of antimicrobial agents: Bc 1, Ch 1, Ct 1, Dd 100, Eb 20, Pf 20 and Pi 50. Plasmid elimination was performed as described by Lyon et al.24 Plasmid DNA transfer to the recipient strain SK982 was performed either by mixed culture or by electroporation with a BioRad Gene Pulser apparatus. Cells were prepared for electroporation as follows. Cultures in 200 ml of brain heart infusion (BHI) broth were incubated at 37°C until an OD,,, of 0.7 was reached. Cells were harvested, washed once in 80 ml of cold (4°C) distilled water and resuspended in 2.4 ml of cold glycerol 10 YO v/v. Plasmid DNA was added to 250-pl cell samples in 0.2-cm cuvettes (BioRad). The Gene Pulser parameters used were : capacitance 25 pFD; voltage 2.5 kV; and pulse controller 1000 ohms. After a single pulse, 1 ml of BHI broth was added to the cells. Samples (100 pl) were then either plated directly on selective BHI agar, or diluted in 10 ml of BHI broth and incubated overnight at 37°C before plating on selective BHI agar.
DNA manipulation procedures
Isolation of plasmid DNA, digestion with restriction endonucleases, agarose gel electrophoresis, and DNA-DNA hybridisation analysis were all performed as described 26 A probe specific for the closely related genes qacA and qacB was prepared by labelling the 0-33-kb PvuII fragment, internal to qacA, from pSK44911 by nick t r a n~l a t i o n~~ with [ W~~P I~A T P .
A qacC probe was prepared by end-labelling27 a 26-mer oligonucleotide (5'-CTTCCAA-TAACTTCAGTACTTATGGC-3') specific to qacCs with [ Y -~~P I~A T P .
Results
Resistance to antiseptics and disinfectants in CNS
In total, 164 clinical isolates of CNS were examined for susceptibility to Eb, Bc and Ct. Resistance to one or more of these compounds, as defined in Materials and methods, was observed in 65 (40%) of the 164 strains tested. The MICs of a range of cationic compounds were determined for 40 of the resistant CNS strains (table I) . Most of the strains were resistant to high concentrations of nearly all of the agents tested. High-level resistance to the diamidines Dd and Pi, which is mediated characteristically by qacA, was observed in 36 of the 40 strains. These 36 strains also displayed levels of resistance to the intercalating dyes Eb and Pf, to the quaternary ammonium compounds Bc and Ct, and to the biguanidine Ch, that were comparable to the resistance phenotype specified by qacA in S. aureus (table I) . The resistance profiles of the other four CNS strains resembled the qacC phenotype expressed in S. aureus-i.e., resistance to the quaternary ammonium compounds and low-level resistance to Eb-with the exception that two of these strains had Ch MICs of 6 mg/L. The activity of a 1 : 10 mixture of Ch and Ct against the 40 CNS strains did not differ significantly from that of Ct alone.
Detection of the qacA and qacC multidrug resistance determinants in C N S DNA-DNA hybridisation analysis was used to investigate whether the S. aureus multidrug resistance genes qacA-C were responsible for the resistance to antiseptics observed in CNS in this study. Probes specific to qacA/B or qacC were prepared as described in Materials and methods, and were hybridised under high stringency conditions with total genomic DNA from the 40 resistant clinical isolates of CNS. Hybridisation of these probes with DNA from the control strains-SK982 (negative control), SK2355 (qacA), SK2721 (qacC) and SK2725 (qacB)+onfirmed the specificity of the probes (data not shown). DNA from 20 strains hybridised with only the qacA/B probe, from four strains with only the qacC probe, and from the remaining 16 CNS strains with both of the probes (table I) . Table I1 lists examples of plasmids and qac determinants carried by representative CNS strains. The hybridisation profiles of 11 of these strains are t Range of sizes of plasmids that hybridised with each of the qac-specific probes in this study.
$ Range of MlCs observed in strains within each hybridisation group. Compounds tested: dyes (Eb, ethidium bromide; Pf, proflavine); QACs, quaternary ammonium compounds (Bc, benzalkonium chloride; Ct, cetyltrimethylammonium bromide); DD, diamidines (Dd, diamidinodiphenylamine dihydrochloride ; Pi, propamidine isethionate) ; BIG, biguanidine (Ch, chlorhexidine diacetate). shown in fig. 1 . In all cases, the probes specific for qacA/B and qacC hybridised with plasmid DNA rather than chromosomal DNA. The qacA/B-specific probe hybridised only with plasmids larger than 10 kb, e.g., those from strains SK30, SK53, SK62, SK76, SK91, SK95, SK252, SK275, SK281, SK352 ( fig. 1 ; lanes a, c, d, e, f, g, h, i, j, k) and SK398 (data not shown). In contrast, qacC was located primarily on small plasmids of 2-3-2.9 kb, e.g., those from strains SK50, SK95, SK252, SK281, SK352 ( fig. 1 ; lanes b, g, h, j and k) and SK2001 (data not shown). However, qacC was also detected on plasmids of c. 11 strain SK275 (fig. 1; lane i) and c. 21 kb in strain SK977 (data not shown).
Comparison of the hybridisation results with the MIC data for the 40 CNS strains indicated that the observed resistance levels correlated well with the expected phenotypes of the qac determinants (table  I) . The 36 CNS strains that displayed resistance to the diamidines Dd and Pi, as well as other characteristics typical of the resistance conferred by qacA (see above), all hybridised with the qacA/B-specific probe. This suggests that these strains contain qacA rather than qacB, since qacB does not confer resistance to the diamidines or to the biguanidines in S. aureus. Strains that contained both qacA and qacC were resistant to higher concentrations of the quaternary ammonium compounds compared with strains containing only qacA. The four strains that contained only qacC displayed resistance to the quaternary ammonium compounds and low-level resistance to the intercalating dyes, but were sensitive to Dd and Pi. Interestingly, two of these strains (SK50 and SK2001) were resistant to Ch, a feature not usually associated with expression of qacC.
Charucterisation of representative C N S plasmids encoding qacA and qacC
Plasmid elimination and transfer experiments were performed to confirm that the observed resistance phenotypes were specified by plasmid-encoded qac genes. Plasmids pSKlO5, pSK107, pSK638, pSK4032 and pSK4769 (table II) , which all hybridised with the qacA-specific probe, could be eliminated at frequencies of 50-85 O/ O from their respective host clinical strains. DNA-DNA hybridisation and MIC determination analysis of these cured derivatives confirmed that there was a concomitant loss of qacA with each plasmid.
Similarly, transfer of these plasmids to the S . aureus recipient strain SK982 by electroporation or mixed culture transfer, or both, resulted in transfer of the qacA determinant. Transfer of plasmid pSKl08, which hybridised with the qacC-specific probe, to strain SK982, followed by analysis of the transcipients by hybridisation and phenotypic characterisation, confirmed that this plasmid carries qacC. The probes specific for qacA and qacC both hybridised to a plasmid or plasmids of c. 11-11-5 kb in CNS strain SK275. Elimination studies revealed that this strain contained two plasmids of 11.5 kb (pSK696) and 11 kb (pSK697), encoding qacA and qacC, respectively, since curing of the latter plasmid resulted in a concomitant loss of qacC, as judged by hybridisation analysis (data not shown).
Selected CNS plasmids were characterised further by restriction endonuclease mapping and DNA-DNA hybridisation analysis of plasmid digests to investigate their possible relationship with qac plasmids from S. aureus. Restriction maps and the location of the qacA or qacC gene, as determined by hybridisation, on each plasmid are presented in fig. 2 . The qacA gene is found typically on members of the pSKl family of plasmids in S. aweus." The 23.5-kb CNS plasmid pSKlO5, which contains qacA, shares extensive restriction map identity with pSKl ( fig. 2) , but contains the gentamicin-tobramycin-kanamycin resistance transposon T114001~~ inserted at a different site compared with other plasmids belonging to the pSK1 family. In contrast, the 13.5-kb qacA CNS plasmids pSK107, pSK4032 and pSK4769, which were virtually indistinguishable, did not share detectable restriction map similarity with members of either the pSKl or the plactamase/heavy-metal resistance family of plasmids. Likewise, the 10.5-kb qacA plasmid pSK638 did not show obvious restriction map similarity with other qacA-containing plasmids.
The qacC gene in S. aureus is located commonly on small plasmids, such as pSK89 ( fig. 2 ), or on large conjugative plasmids, such as pSK41.' Although the CNS qacC plasmid pSK108 was approximately the same size as pSK89, it appeared to be structurally distinct with no apparent restriction map similarity. The larger CNS qacC plasmid pSK697 did not share obvious restriction map similarity with any plasmids characterised previously from S. aureus.
Discussion
The multidrug export gene qacA is located on the pSK 1 family of multiresistance plasmidslO which have been isolated frequently from strains associated with hospital outbreaks of S . aureus infection in Australia and the UK during the 198O~.l*~O The qacC resistance gene has been found on large, conjugative plasmids in S. aureus clinical strains isolated since the mid-1970s in Europe, USA and Japan,', 14 were mapped for all of the above plasmids and are indicated by: B, BglII; 0, EcoRI; V, EcoRV; A, HindII; +, HindIII; 0 , HpaII; V, PuulI; 0, SaZI. Additional restriction endonuclease sites were mapped for pSK89 and pSK108 and are shown on the enlarged maps of these plasmids: b, AccI; D, MboI; A, PstI; *, RsaI; 0, TaqI. The following genes are represented in this figure: dfrA, trimethoprim-resistant dihydrofolate reductase qacA and qacC, multidrug export genes, investigated in this report. The aminoglycoside resistance transposon Tn400Z2' and the trimethoprim resistance transposon T114003~' are also indicated; the IS256 and IS257 repeats associated with these elements are represented by hatched and solid boxes, respectively. The dashed lines on the map of pSKlO5 correspond to regions which are not present on pSKlO5 compared with the closely related plasmid pSKl. The maps of pSKllO and pSK89' were as published previously.
presented in this study indicate that CNS strains isolated from Australian hospitals in the early 1980s contained either or both qacA and qacC. The prevalance of these multidrug export genes in clinical isolates of S. aureus and CNS is probably a result of selective pressure imposed by the use of agents such as acriflavine, Bc, Ch, cetylpyridinium chloride, Ct (cetrimide) and Dd as part of commonly employed antiseptic and disinfectant formulations.6* '' The observation that qac genes are often located on plasmids encoding multiple antibiotic resistance, and that these plasmids are found typically in hospital isolates rather than community isolates, supports the suggestion that resistance to these cationic antimicrobial compounds is maintained because of selective pressures in the hospital environment. In this study, 40% of the CNS isolates contained both qacA and qacC. The combination of two qac genes in the same isolate has not been reported previously in S. aureus, and suggests that there may be a selective advantage in having both qacA and qacC compared to only qacA. A range of MICs of each compound was observed in different isolates containing the same qac genes (table I) . This resulted, presumably, either from differential expression of the respective qac genes in the different clinical strains, or from variations in the levels of background resistance in these strains. The basis of the resistance to Ch observed in the two CNS strains that harboured small qacC-carrying plasmids remains to be clarified. This resistance may result from an alteration in the substrate binding site of the QacC protein that enables it to recognise Ch. Alternatively, Ch resistance may be a consequence of an as yet uncharacterised resistance
